We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-18.86%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$94.9M
AUM Growth
-$11.6B
Cap. Flow
+$352M
Cap. Flow %
370.94%
Top 10 Hldgs %
49.64%
Holding
849
New
169
Increased
282
Reduced
215
Closed
183

Sector Composition

Rank Sector Weight
1 Energy 67.78%
2 Healthcare 2.32%
3 Materials 2.09%
4 Financials 1.64%
5 Consumer Discretionary 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TREE icon
626
LendingTree
TREE
$544M
$4.02K ﹤0.01%
+4,317
New +$437K
LVS icon
627
Las Vegas Sands
LVS
$30.5B
$4K ﹤0.01%
10,533
+633
+6% +$31.9K
GMLP
628
DELISTED
Golar LNG Partners LP
GMLP
$3.99K ﹤0.01%
27,178
+6,493
+31% +$133K
AMAG
629
DELISTED
AMAG Pharmaceuticals
AMAG
$3.92K ﹤0.01%
+9,877
New +$613K
SLCA
630
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$3.9K ﹤0.01%
27,660
+9,177
+50% +$196K
OXY icon
631
Occidental Petroleum
OXY
$57B
$3.81K ﹤0.01%
5,764
+669
+13% +$46.7K
TISI icon
632
Team
TISI
$77.7M
$3.78K ﹤0.01%
+1,177
New +$504K
VTAE
633
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$3.77K ﹤0.01%
34,204
+12,526
+58% +$133K
SWFT
634
DELISTED
Swift Transportation Company
SWFT
$3.75K ﹤0.01%
+24,967
New +$526K
IWP icon
635
iShares Russell Mid-Cap Growth ETF
IWP
$20B
$3.75K ﹤0.01%
8,452
-50
-0.6% -$2.37K
LCI
636
DELISTED
Lannett Company, Inc.
LCI
$3.71K ﹤0.01%
2,232
+245
+12% +$53.8K
ANIP icon
637
ANI Pharmaceuticals
ANIP
$1.77B
$3.71K ﹤0.01%
9,381
+954
+11% +$54.3K
ELDN icon
638
Eledon Pharmaceuticals
ELDN
$276M
$3.63K ﹤0.01%
217
+80
+58% +$165K
FOMX
639
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3.45K ﹤0.01%
47,089
+17,243
+58% +$176K
XNPT
640
DELISTED
XENOPORT, INC.
XNPT
$3.43K ﹤0.01%
98,730
+36,448
+59% +$230K
RIGL icon
641
Rigel Pharmaceuticals
RIGL
$680M
$3.42K ﹤0.01%
13,853
+5,104
+58% +$152K
AGTC
642
DELISTED
Applied Genetic Technologies Corporation
AGTC
$3.39K ﹤0.01%
25,811
+9,512
+58% +$158K
LUMO
643
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$3.38K ﹤0.01%
+1,049
New +$461K
CQP icon
644
Cheniere Energy
CQP
$31.8B
$3.31K ﹤0.01%
12,577
-46
-0.4% -$1.35K
PSXP
645
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$3.31K ﹤0.01%
6,709
-33
-0.5% -$1.92K
HMY icon
646
Harmony Gold Mining
HMY
$9.92B
$3.25K ﹤0.01%
538,235
+164,588
+44% +$157K
EOG icon
647
EOG Resources
EOG
$78B
$3.07K ﹤0.01%
4,220
+605
+17% +$47K
WES icon
648
Western Midstream Partners
WES
$19.6B
$3.02K ﹤0.01%
7,658
+53
+0.7% +$2.83K
CNH
649
CNH Industrial
CNH
$13.8B
$3.01K ﹤0.01%
53,039
-6,049
-10% -$44K
GNCA
650
DELISTED
Genocea Biosciences, Inc.
GNCA
$3.01K ﹤0.01%
5,490
+2,498
+83% +$248K

Similar funds

ALPS Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, ALPS Advisors held 849 positions worth $94.9M, down 99% from $11.7B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

ALPS Advisors deployed $352M of net new capital in Q3 2015, opening 169 new positions and adding to 282 existing holdings. Its largest new stake was Brookfield: 4,795,507 shares worth $52.9K.

By sector, the portfolio is most concentrated in Energy at 68% of assets, down from 70% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Magellan Midstream Partners, L.P., an estimated $21.8M trimmed.

  • ALPS Advisors's largest Q3 2015 buy was Brookfield: 4,795,507 shares worth $52.9K.
  • ALPS Advisors added most to Plains All American Pipeline in Q3 2015, an estimated $71.8M increase.
  • ALPS Advisors's biggest Q3 2015 reduction was Magellan Midstream Partners, L.P., cutting an estimated $21.8M.
  • ALPS Advisors fully exited CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE) in Q3 2015, selling an estimated $122M.
  • ALPS Advisors's ten largest holdings make up 50% of its $94.9M portfolio in Q3 2015.
  • ALPS Advisors opened 169 new positions and closed 183 in Q3 2015.
  • ALPS Advisors's portfolio value fell 99% quarter-over-quarter to $94.9M.

Based on ALPS Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.